Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should hepatitis C virus infection be a contraindication to renal transplantation?

Nature Clinical Practice Nephrology volume 4, pages 304–305 (2008)Cite this article

boxed-textArango J et al. (2008) Kidney graft survival in patients with hepatitis C: a single center experience. Clin Transplant 22: 16–19

Although HCV infection is associated with decreased patient and graft survival rates in renal transplant recipients, the survival advantage provided by transplantation, as compared to continuing on dialysis, favors transplantation in such patients

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fabrizi F et al. (2007) Hepatitis C virus infection and the dialysis patient. Semin Dial 20: 416–422

    Article  Google Scholar 

  2. US Renal Data System (online 2007) USRDS 2007 Annual data report atlas: chronic kidney disease and end-stage renal disease in the United States [http://www.usrds.org/atlas.htm] (accessed 6 February 2008)

  3. Forman JP et al. (2004) Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol 15: 3249–3255

    Article  Google Scholar 

  4. 2006 annual report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 1996–2005 (2006) Rockville, MD: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation

  5. Fabrizi F et al. (2005) Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 5: 1452–1461

    Article  CAS  Google Scholar 

  6. Maluf DG et al. (2007) Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival. Transplantation 83: 853–857

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Locum Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. MJ Aull is a Transplant Clinical Pharmacist and M Suthanthiran is Stanton Griffis Distinguished Professor and Chief of Nephrology and Transplantation Medicine, both at New York Presbyterian Hospital–Weill Cornell Medical Center, New York, NY, USA.,

    Meredith J Aull & Manikkam Suthanthiran

Authors
  1. Meredith J Aull
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manikkam Suthanthiran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meredith J Aull.

Ethics declarations

Competing interests

MJ Aull has acted as a consultant for Genzyme and for Astellas Pharma.

M Suthanthiran has acted as a consultant for Astellas Pharma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aull, M., Suthanthiran, M. Should hepatitis C virus infection be a contraindication to renal transplantation?. Nat Rev Nephrol 4, 304–305 (2008). https://doi.org/10.1038/ncpneph0801

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0801

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing